The copper-iron connection: Hereditary accruloplasminemia

Seminars in Hematology

Volumn 39, Issue 4, 2002, Pages 282-289

  Nittis, Thalia ^a   Gitlin, Jonathan D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACERULOPASMINEMIA; ASTROCYTE; AUTOSOMAL RECESSIVE DISORDER; CERULOPLASMIN BLOOD LEVEL; DEMENTIA; DIABETES MELLITUS; DYSARTHRIA; DYSTONIA; ENZYME ACTIVITY; FERRITIN BLOOD LEVEL; GENE FUNCTION; GENE MUTATION; HUMAN; IRON OVERLOAD; IRON STORAGE; MICROCYTIC ANEMIA; NEUROLOGIC DISEASE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RETINA DEGENERATION; REVIEW; DEGENERATIVE DISEASE; DISORDERS OF METAL METABOLISM; ENZYMOLOGY; FAMILY HEALTH; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY;

CERULOPLASMIN; COPPER; IRON;

CERULOPLASMIN; COPPER; FAMILY HEALTH; IRON; METAL METABOLISM, INBORN ERRORS; MUTATION; NEURODEGENERATIVE DISEASES;

EID: 0036800145     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/shem.2002.35633     Document Type: Article

References (63)

1. Abboud S, Haile DJ: A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275:19906-19912, 2000
2. Askwith C, Eide D, VanHo A, et al: The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell 76:403-410, 1994
3. Calabrese L, Carbonaro M, Musci G: Presence of coupled trinuclear copper cluster in mammalian ceruloplasmin is essential for efficient electron transfer to oxygen. J Biol Chem 264:6183-6187, 1989
4. Cartwright GE, Markowitz H, Shields S, et al: Studies on copper metabolism. XXIX. Am J Med 28:555-563, 1960
5. Cox DW: Factors influencing serum ceruloplasmin levels in normal individuals. J Lab Clin Med 68:893-904, 1966
6. Craven CM, Alexander J, Eldridge M, et al: Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: A rodent model for hemochromatosis. Proc Natl Acad Sci 84:3457-3461, 1987
7. Curtis AR, Fey C, Morris CM, et al: Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28:350-354, 2001
8. Daimon M, Yamatani K, Igarashi M, et al: Fine structure of the human ceruloplasmin gene. Biochem Biophys Res Commun 208:1028-1035, 1995
9. Daimon M, Kato T, Kawanami T, et al: A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus. Biochem Biophys Res Commun 217:89-21795, 1995
10. Daimon M, Moriai S, Susa S, et al: Hypocaeruloplasminaemia with heteroallelic caeruloplasmin gene mutation: MRI of the brain. Neurorad 41:185-187, 1999
11. Daimon M, Susa S, Ohizumi T, et al: A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM). Tohoku J Exp Med 191: 119-125, 2000
12. Davis-Kaplan SR, Askwith CC, Bengtzen AC, et al: Chloride is an allosteric effector of copper assembly for the yeast multicopper oxidase Fet3p: An unexpected role for intracellular chloride channels. Proc Natl Acad Sci USA 95:13641-13645, 1998
13. Donovan A, Brownlie A, Zhou Y, et al: Positional cloning of zebrafish ferroportinl identifies a conserved vertebrate iron exporter. Nature 403:776-781, 2000
14. Edwards CQ, Williams DM, Cartwright GE: Hereditary hypoceruloplasminemia. Clin Genet 15:311-316, 1979
15. Fortna RR, Watson HA, Nyquist SE: Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed by rat Sertoli cells and is concentrated in detergent-insoluble membrane fractions. Biol Reprod 61:1042-1049, 1999
16. Gitlin D, Janeway CA: Turnover of the copper and protein moieties of ceruloplasmin. Nature 185:693, 1960
17. Gitlin D, Biasucci A: Development of gamma G, gamma A, gamma M, beta 1C, beta 1A, Cl esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antritrypsin, orosomucoid, beta-lipoprotein, alpha 2 macroglobulin and prealbumin in the human conceptus. J Clin Invest 48:1433-1446, 1966
18. Gitlin JD, Schroeder JJ, Lee-Ambrose LM, et al: Mechanisms of caeruloplasmin biosynthesis in normal and copper-deficient rats. Biochem J 282:835-839, 1992
19. Harris ZL, Takahashi Y, Miyajima H, et al: Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 92:2539-2543, 1995
20. Harris ZL, Migas MD, Hughes AE, et al: Familial dementia due to a frameshift mutation in the ceruloplasmin gene. Q J Med 89:355-359, 1996
21. Harris ZL, Durley AP, Man TK, et al: Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA 96:10812-10817, 1999
22. Hellman NE, Schaefer M, Gehrke S, et al: Hepatic iron overload in aceruloplasminaemia. Gut 47:858-860, 2000
23. Hellman NE, Kono S, Miyajima H, et al: Biochemical analysis of a missense mutation in aceruloplasminemia. J Biol Chem 277:1375-1380, 2002
24. Holmberg CG, Laurell CB: Investigations in serum copper. II. Isolation of the copper-containing protein and a description of some of its properties. Acta Chem Scand 2:550-556, 1948
25. Holtzman NA, Gaumnitz BM: Identification of an apoceruloplasmin-like substance in the plasma of copper-deficient rats. J Biol Chem 245:2350-2353, 1970
26. Holtzman NA, Gaumnitz BM: Studies on the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma. J Biol Chem 245:2354-2358, 1970
27. Hung IH, Suzuki M, Yamaguchi Y, et al: Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J Biol Chem 272:21461-21466, 1997
28. Klomp LWJ, Farhangrazi ZS, Dugan LL, et al: Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest 98:207-215, 1996
29. Klomp LWJ, Gitlin JD: Expression of the ceruloplasmin gene in the human retina and brain: Implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet 5:1989-1996, 1996
30. Kohno S, Miyajima H, Takahashi Y, et al: Aceruloplasminemia with a novel mutation associated with parkinsonism. Neurogenetics 2:237-248, 2000
31. Koschinsky ML, Chow BK-C, Schwartz J, et al: Isolation and characterization of a processed gene for human ceruloplasmin. Biochemistry 26:7760-7767, 1987
32. Lee GR, Nacht S, Lukens JN, et al: Iron metabolism in copper-deficient swine. J Clin Invest 47:2058-2069, 1968
33. Logan JL, Harveyson KB, Wisdom GB, et al: Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Q J Med 87:663-670, 1994
34. McKie AT, Marciani P, Rolfs A, et al: A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5:299-209, 2000
35. Meyer LA, Durley AP, Prohaska JR, et al: Copper transport and metabolism are normal in aceruloplasminemic mice. J Biol Chem 276:36857-36861, 2001
36. Miyajima H, Nishimura Y, Mizoguchi K, et al: Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37:761-767, 1987
37. Miyajima H, Takahashi Y, Serizawa M, et al: Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Radic Biol Med 20:757-760, 1996
38. Miyajima H, Takahashi Y, Kamata T, et al: Use of desferrioxamine in the treatment of aceruloplasminemia. Ann Neurol 41:404-407, 1997
39. Miyajima H, Fujimoto M, Kohno S, et al: CSF abnormalities in patients with aceruloplasminemia. Neurology 51:1188-1190, 1998
40. Miyajima H, Adachi J, Tatsuno Y, et al: Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia. Neurology 50:130-136, 1998
41. Miyajima H, Kohno S, Takahashi Y, et al: Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology 53:617-629, 1999
42. Miyajima H, Kono S, Takahashi Y, et al: Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 57:2205-2210, 2001
43. Miyajima H, Adachi J, Kohno S, et al: Increased oxysterols associated with iron accumulation in the brains and visceral organs of acaeruloplasminaemia patients, Q J Med 94:417-422, 2001
44. Montosi G, Donovan A, Totaro A, et al: Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619-623, 2001
45. Morita H, Ikeda S, Yamamoto K, et al: Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a Japanese family. Ann Neurol 37:646-656, 1995
46. Njajou OT, Vaessen N, Joosse M, et al: Mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28:213-214, 2001
47. Okamoto N, Wada S, Oga T, et al: Hereditary ceruloplasmin deficiency with hemosiderosis. Hum Genet 97:755-758, 1996
48. Osaki S, Johnson D, Frieden E: The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 241:2746-2757, 1966
49. Osaki S, Johnson DA, Frieden E: The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase. J Biol Chem 246:3018-3023, 1971
50. Patel BN, David S: A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem 272:20185-20190, 1997
51. Patel BN, Dunn RJ, David S: Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem 275:4305-4310, 2000
52. Roeser HP, Lee GR, Nacht S, et al: The role of ceruloplasmin in iron metabolism. J Clin Invest 49:2408-2417, 1970
53. Salzer JL, Lovejoy L, Linder MC, et al: Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J Neurosci Res 54:147-157, 1998
54. Sato M, Gitlin JD: Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J Biol Chem 266:5128-5134, 1991
55. Schaefer M, Hopkins R, Failla M et al: Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver. Am J Physiol 276:G639-G646, 1999
56. Scheinberg IH, Gitlin D: Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science 116:484-489, 1952
57. Stearman R, Yuan DS, Yamaguchi-Iwa Y, et al: A permeaseoxidase complex involved in high-affinity iron uptake in yeast. Science 271:1552-1557, 1996
58. Takahashi Y, Miyajima H, Shirabe S, et al: Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet 51:81-84, 1995
59. Vulpe CD, Kuo YM, Murphy TL, et al: Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 21:195-199, 1999
60. Yazaki M, Yoshida K, Nakamura A, et al: A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis. J Neurol Sci 156:30-34, 1998
61. Yonekawa M, Okabe T, Asamoto Y, et al: A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma. Eur Neurol 42:157-162, 1999
62. Yoshida K, Furihata K, Takeda S, et al: A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 9:267-272, 1995
63. Yoshida K, Kaneko K, Miyajima H, et al: Increased lipid peroxidation in the brains of aceruloplasminemia patients. J Neurol Sci 175:91-95, 2000